1. Home
  2. News
  3. Cynata Therapeutics Limited
  4. Phase 2 Trial of CYP-001 in aGvHD Open for Recruitment
More Cynata Therapeutics Limited news
Cynata Therapeutics LimitedASX: CYP

Phase 2 Trial of CYP-001 in aGvHD Open for Recruitment

Aug 9, 2023 at 11:24 PM EDT · Issued by Cynata Therapeutics Limited

Filed with ASX · Aug 9, 2023 at 11:24 PM EDT · 1 page · English

On 6ix: 6ix.com/news/phase-2-trial-of-cyp-001-in-agvhd-open-for-recruitment

Cynata Therapeutics Limited on 6ix

Story so far

  • Ethics Committee Approval for Proposed aGvHD Phase 2 TrialApr 12, 2023
  • Cynata Adds New Sites for DFU Clinical TrialMar 16, 2023
  • Cynata Receives IRB Approval for aGvHD Clinical TrialJan 30, 2023

Earlier from Cynata Therapeutics

  • Strategic Review of Cynata Clinical Development PortfolioJul 24, 2023
  • Cynata announces CEO succession and Board changesJun 29, 2023
  • Cynata Completes Oversubscribed Share Purchase PlanMay 10, 2023
  • Share Purchase Plan Booklet & Option ProspectusApr 19, 2023
  • Ethics Committee Approval for Proposed aGvHD Phase 2 TrialApr 11, 2023

Later from Cynata Therapeutics

  • Approval of Clinical Trial of CYP-001 in Kidney TransplantAug 20, 2023
  • Cynata Receives $2.315m R&D Tax Incentive RefundNov 13, 2023
  • Phase 2 Trial of CYP-001 in aGvHD Approved in TurkeyDec 6, 2023
  • Recruitment Completed in Phase 3 OA Clinical TrialDec 12, 2023
  • Encouraging Initial Data from CYP-006TK DFU TrialFeb 25, 2024
All Cynata Therapeutics news releases↗

Follow Cynata Therapeutics into a list and get an email when it puts out news.

Follow Cynata Therapeutics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer